Damora Therapeutics, Inc. GLTO
21.58 USD 0.00 (+0.00%)
Jun 4, 2026, 12:02 PM EDT
21.58 Day range 23.54
52-week range unavailable
- YTD
- -6.21%
- 1 year
- +659.86%
Ownership
Held by insiders 3.46%
Held by institutions 12.03%
Float held by institutions 12.46%
Institutions 11
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Novo Holdings A/S | 7.59% | 99,913 | 471.66K | Sep 29, 2024 |
| Renaissance Technologies, LLC | 1.62% | 21,382 | 100.94K | Sep 29, 2024 |
| UBS Group AG | 0.39% | 5,099 | 24.07K | Sep 29, 2024 |
| Bank of America Corporation | 0.09% | 1,225 | 5.78K | Sep 29, 2024 |
| Blackrock Inc. | 0.04% | 490 | 2.31K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.03% | 346 | 1.63K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.65% | 8,508 | 40.16K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.34% | 4,541 | 21.44K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.19% | 2,453 | 11.58K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.09% | 1,190 | 5.62K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.04% | 469 | 2.21K | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHRISTGAU STEPHAN | Director | Purchase | Nov 1, 2020 | 0 |
| FREVE JONATHAN | Chief Financial Officer | Purchase | Dec 2, 2021 | 12,000 |
| KHUONG CHAU QUANG | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Nov 1, 2020 | 0 |
| LINDMARK BERTIL | Officer | Purchase | Mar 21, 2022 | 16,604 |
| MUNSHI AMIT D | Director | Conversion of Exercise of derivative security | Nov 1, 2020 | 4,793 |
| NOVO HOLDINGS A/S | Beneficial Owner of more than 10% of a Class of Security | Purchase | Nov 1, 2020 | 2,497,790 |